Equities

Eiken Chemical Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Eiken Chemical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,560.00
  • Today's Change-8.00 / -0.31%
  • Shares traded71.20k
  • 1 Year change+17.38%
  • Beta0.5308
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Eiken Chemical Co Ltd is a Japan-based company principally engaged in the manufacturing and sales of test drugs. Through its subsidiaries, the Company conducts contract the manufacturing of diagnostic reagents and purchases, manufactures and sells diagnostic reagents. The products and services include microbial testing reagents, urine testing reagents, immuno-serological test reagents, biochemical testing reagents and instrument food environment-related media. The Company sells its products in Japan and overseas markets.

  • Revenue in JPY (TTM)41.28bn
  • Net income in JPY3.83bn
  • Incorporated1939
  • Employees702.00
  • Location
    Eiken Chemical Co LtdYamaguchi Bldg.7, 4-19-9, TaitoTAITO-KU 110-8408JapanJPN
  • Phone+81 358463305
  • Fax+81 358463476
  • Websitehttps://www.eiken.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
France Bed Holdings Co Ltd61.19bn2.72bn46.39bn1.81k18.631.135.820.758171.6571.651,627.811,177.550.90172.946.0633,769,870.004.014.195.055.6555.0053.374.454.781.951,504.330.244146.932.382.93-6.0014.15-2.507.39
Medikit Co Ltd23.68bn3.09bn48.12bn989.0014.290.961910.572.03211.98211.981,621.483,149.960.46433.144.1023,940,550.006.075.706.726.3038.5539.3713.0713.845.33--0.000241.813.222.54-1.820.854821.5712.47
Japan Eyewear Holdings Co Ltd17.99bn4.22bn48.17bn580.0011.562.838.042.68172.64172.64736.69704.930.47411.8016.5631,022,410.0011.13--12.75--79.15--23.48--0.785318.060.4966--23.20--80.15------
Nagaileben Co Ltd16.69bn2.48bn56.22bn501.0022.691.4520.403.3780.6280.62544.001,263.590.38981.324.2033,321,640.005.786.906.137.4339.3743.3514.8418.6810.68--0.0067.123.48-0.097-8.81-5.8216.970.00
TAUNS Laboratories Inc14.58bn3.98bn60.01bn316.0015.393.7512.764.1236.6636.66136.75150.350.42710.85793.2746,129,040.0011.65--16.30--65.82--27.28--0.848643.440.557--1.05--9.38------
Kitazato Corp10.98bn3.98bn63.88bn86.0016.033.2915.325.8299.6099.60274.45485.650.57231.838.92--20.77--21.73--66.93--36.29--14.33--0.00--2.20---4.63------
Shofu Inc38.97bn4.25bn64.96bn1.41k15.251.4211.991.67118.98118.981,092.321,279.850.75741.239.8127,577,490.008.287.279.278.2459.4558.4110.949.752.72--0.0032.9910.318.1918.1143.72-3.1930.39
Eiken Chemical Co Ltd41.28bn3.83bn88.70bn702.0022.131.9413.952.15116.07116.071,238.231,326.890.66692.863.2358,797,720.006.197.238.089.1039.6345.179.2910.641.3733.810.064240.761.222.07-15.41-8.8313.8912.05
Japan Lifeline Co Ltd58.20bn9.07bn101.25bn1.25k10.981.589.411.74129.28129.28829.90900.800.79181.293.9746,563,200.0012.348.9914.8111.2659.7858.1215.5812.652.09--0.048672.6310.171.8123.983.76-9.0512.82
Data as of Feb 13 2026. Currency figures normalised to Eiken Chemical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

51.66%Per cent of shares held by top holders
HolderShares% Held
Dalton Investments, Inc.as of 14 Nov 20256.82m19.75%
Rising Sun Management Ltd.as of 30 Jun 20253.23m9.36%
Asset Value Investors Ltd.as of 26 Nov 20252.55m7.37%
The Vanguard Group, Inc.as of 07 Jan 20261.08m3.13%
Nomura Asset Management Co., Ltd.as of 08 Jan 2026885.10k2.56%
Amova Asset Management Co., Ltd.as of 15 Sep 2025877.90k2.54%
Sumitomo Mitsui Trust Asset Management Co., Ltd.as of 15 Sep 2025824.40k2.39%
MFS International Singapore Pte Ltd.as of 31 Dec 2025679.50k1.97%
Nippon Value Investors KKas of 31 Jul 2025445.30k1.29%
Comgest Asset Management International Ltd.as of 31 Jul 2025445.30k1.29%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.